Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. - Wikidata - awgldk - TriplyDB

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.

http://www.wikidata.org/entity/Q33654315

about

Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14 Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13 Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis.MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability.An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration In vivo bioluminescence imaging of hyperglycemia exacerbating stem cells on choroidal neovascularization in mice Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis.Matrix metalloproteinase-13 mediated degradation of hyaluronic acid-based matrices orchestrates stem cell engraftment through vascular integration.Retinal MMP-12, MMP-13, TIMP-1, and TIMP-2 expression in murine experimental retinal detachment.Emerging options for the management of age-related macular degeneration with stem cells.In vivo bioluminescence imaging monitoring of stem cells' participation in choroidal neovascularization.

P2860

Q26765959-EF8B120C-1A29-426F-B4EE-BCCF943CBBB3 Q27333560-5B08C2F6-0EE3-4E8C-940F-D08F0E10D2DA Q28469505-BD0B3562-951A-4276-AB61-DBFFBE736068 Q34183523-E7F67CFD-7D38-4145-8520-6D7D478D73B8 Q34374399-B4BB7BDE-17A2-4BEF-9706-49238E3CE9F3 Q34755199-9B15767D-39F8-4E83-A8A6-6AB25BBCBB8A Q34791186-1A6301A3-7F93-4221-922A-91163CAB22E8 Q36013023-411C40E3-11C7-49AD-9B92-3554C5FA74AE Q36343778-1CC40C8B-8362-4C20-8953-81676405843F Q36467398-E54E5551-7164-49AB-823C-0A7161987752 Q36852193-8CBEB401-E595-416B-A0D3-1C6B2EF88770 Q37691345-856F38F4-A6D5-4094-81F1-831F6E596900 Q38160460-FAAED000-AA5D-4B84-A1E3-E973B8A66760 Q46165770-27A58BA0-CF6D-4EAC-9434-B1D3E330F654

P2860

Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.

http://www.wikidata.org/entity/Q33654315

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Bone marrow-derived mesenchyma ...... choroidal neovascularization.

@ast

Bone marrow-derived mesenchyma ...... choroidal neovascularization.

@en

type

label

Bone marrow-derived mesenchyma ...... choroidal neovascularization.

@ast

Bone marrow-derived mesenchyma ...... choroidal neovascularization.

@en

prefLabel

Bone marrow-derived mesenchyma ...... choroidal neovascularization.

@ast

Bone marrow-derived mesenchyma ...... choroidal neovascularization.

@en

P1433

Q33654315-C14FB497-8E44-40D3-8740-009414C41DDC

P1476

Q33654315-0D216D3A-912C-4AB9-A972-9610260D5E07

P2093

Q33654315-24C9F0ED-CBF4-4CAC-AE9F-14E921B1CF85

Q33654315-53AE0F0F-6403-4811-8AD2-9EA10BF4E2E1

Q33654315-7986411E-0FB1-4D1E-9A21-8D74584746E9

Q33654315-82C844BE-8389-4DCB-8359-FEC391CA48D2

Q33654315-8B137C75-B73B-42C2-90A5-1DD23E07C236

Q33654315-91F76457-5C87-41A4-8715-5D06D4FF511C

Q33654315-9AF324CF-94E1-40A4-87EC-737DA3EFD672

Q33654315-A7295E18-479A-4679-9624-419FFE6109F7

Q33654315-B511AE16-CD5B-4D6C-8416-20D8312019DB

Q33654315-E1AB7319-3374-42B8-B964-FA57A44A41C2

P2860

Q33654315-00EE218A-424D-45BA-BF2F-D2353845DB77

Q33654315-0364E0C9-6195-4F7E-A700-6772E3FDB43C

Q33654315-0DD29FDD-4C15-49E1-BD05-ED75CC118247

Q33654315-1C443897-AA83-4052-91CD-C442DD766CEB

Q33654315-22961AC5-B118-4C3E-ADE9-1748168C9364

Q33654315-27FE4A81-260C-4876-B866-677FC28E25BB

Q33654315-285A222F-ED0D-4A5B-8475-80D15B499246

Q33654315-2B48DFA4-45C5-44E7-A66F-EBD060A0FB97

Q33654315-2FB0A964-2B50-4F23-842B-C4B9D3A86FD0

Q33654315-3CFFA6B4-8C61-4602-9371-501311963146

P2888

Q33654315-1137AA9D-2178-4270-B1D8-3FAECC025A2E

P304

Q33654315-A24C138D-EA3F-40DC-B59E-4AEDF7B7534D

P31

Q33654315-7C0A885F-D69E-42F3-854A-2C5B8D5D3F7E

P356

Q33654315-63596FCA-5945-48A7-B247-6A4DC9BD1657

P433

Q33654315-EBE5E342-C4C1-4578-A19C-0300E148354D

P478

Q33654315-A0F46373-830B-4CF3-9860-F08F6CDD7148

P50

Q33654315-3D2AF7BB-BCD4-4E68-91D4-E718D91D6A27

P577

Q33654315-33EDB6EB-3BA8-431B-B135-CAA959BCA3D0

P5875

Q33654315-F836596A-216B-4DEE-8825-1BCF16C7E2A7

P698

Q33654315-32999952-12A1-4C36-89AA-9450BCCF8788

P921

Q33654315-88C6F14A-A6F9-43D9-AE5B-1167DC3A65FE

P356

S00018-010-0476-6

P1433

Cellular and Molecular Life Sciences

P1476

Bone marrow-derived mesenchyma ...... choroidal neovascularization.

@en

P2093

Agnès Noel

http://www.w3.org/2001/XMLSchema#string

Benoit Detry

http://www.w3.org/2001/XMLSchema#string

Carine Munaut

http://www.w3.org/2001/XMLSchema#string

Jean-Marie Rakic

http://www.w3.org/2001/XMLSchema#string

Jenny Paupert

http://www.w3.org/2001/XMLSchema#string

Julie Lecomte

http://www.w3.org/2001/XMLSchema#string

Krystel Louis

http://www.w3.org/2001/XMLSchema#string

Pierre Blaise

http://www.w3.org/2001/XMLSchema#string

Sandrine Bekaert

http://www.w3.org/2001/XMLSchema#string

Silvia Blacher

http://www.w3.org/2001/XMLSchema#string

P2860

The structure, regulation, and function of human matrix metalloproteinase-13

Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme

Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification

Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling

Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)

Angiogenesis as a therapeutic target

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

Matrix metalloproteinase-9 contributes to choroidal neovascularization.

P2888

s00018-010-0476-6

P304

677-686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-010-0476-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Foidart

P577

2010-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45604413

http://www.w3.org/2001/XMLSchema#string

P698

20700625

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization